ZEAL — Zealand Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK16.22bn
- DKK2.17bn
- DKK9.21bn
Brief: Zealand Pharma Gets Positive CHMP Opinion For Zeydovio For Treatment Of Short Bowel Syndrome
Barclays stays neutral on European pharma for 2027
JPM raises Novo Nordisk PT, but sticks with 'neutral' due to limited growth
Europe Research Roundup: DIGI Spain, M&S, Next
Brief: Zealand Pharma Enters Into $100 Mln Royalty Purchase, Sale Agreement With Royalty Pharma
Denmark's Zealand Pharma H1 revenue, profit fall sharply
Brief: Zealand Pharma Keeps Financial Guidance For 2026 Unchanged
Brief: Zealand Pharma Enters Into A USD 100 Million Royalty Purchase And Sale Agreement With Royalty Pharma
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data
Jefferies cuts Zealand Pharma on distance to key catalysts
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Zealand falls as Berenberg cuts to 'hold' on fading survodutide hopes
Europe Research Roundup: Aixtron, Lenzing, Novo Nordisk
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Live Markets: Welcome to ECB week
Live Markets: Why the oil price hasn't broken higher? Soc Gen's take
Live Markets: Not as low as feared